Early Access

10-QPeriod: Q1 FY2005

Elevance Health, Inc. Quarterly Report for Q1 Ended Mar 31, 2005

Filed May 4, 2005For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported robust financial performance for the first quarter ended March 31, 2005, marked by significant revenue growth primarily driven by the merger with WellPoint Health Networks Inc. (WHN) completed in late 2004. Total operating revenue more than doubled year-over-year, reaching $10.96 billion, with net income also showing substantial improvement, up 107% to $611.7 million. Key drivers for the quarter include strong membership growth across various segments, particularly in Large Group and BlueCard businesses, contributing to a 148% increase in premiums. The company also saw notable growth in administrative fees and specialty revenues. Despite increased benefit expenses reflecting higher healthcare utilization and costs, the company managed to improve its selling, general, and administrative expense ratio, demonstrating operational leverage post-merger. The company also announced a definitive agreement to acquire Lumenos, Inc., a leader in consumer-directed health programs, signaling continued strategic expansion.

Key Highlights

  • 1Total operating revenue surged to $10.96 billion, a 145% increase year-over-year, largely due to the integration of WellPoint Health Networks Inc. (WHN) merger.
  • 2Net income more than doubled to $611.7 million, up 107% from the prior year's quarter.
  • 3Medical membership grew by 5% to 28.5 million members, with notable increases in Large Group (4%) and BlueCard (14%) segments.
  • 4Premiums rose by 148% to $10.16 billion, driven by premium rate increases and higher membership in key segments.
  • 5Selling, general, and administrative (SG&A) expense ratio improved by 130 basis points to 15.8%, indicating effective cost management post-merger.
  • 6The company announced a definitive agreement to acquire Lumenos, Inc., a consumer-directed health programs leader, for approximately $185 million, expected to close in Q2 2005.
  • 7A 2-for-1 stock split was approved by the Board of Directors on April 25, 2005, with retroactive adjustment to EPS data.

Frequently Asked Questions